Stay updated on CAB-ROR2-ADC: Phase 1/2 Clinical Trial
Sign up to get notified when there's something new on the CAB-ROR2-ADC: Phase 1/2 Clinical Trial page.

Latest updates to the CAB-ROR2-ADC: Phase 1/2 Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedAdded a government funding notice and a v3.2.0 revision tag; removed the previous v3.1.0 tag. If any time-sensitive content (operating status) is now present, it should be considered updated.SummaryDifference3%
- Check18 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedUpdated the revision to v3.0.2 and removed the Back to Top element. No core content, pricing, stock, or time-slot information was affected.SummaryDifference0.2%
- Check40 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.2%
- Check47 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new facility names and locations, particularly in Poland and Taiwan, as well as the introduction of new medical topics related to cancer and respiratory diseases. Notably, previous entries have been removed, including some location details and specific cancer-related topics.SummaryDifference9%
- Check61 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to CAB-ROR2-ADC: Phase 1/2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAB-ROR2-ADC: Phase 1/2 Clinical Trial page.